Phase I/II study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032 Meeting Abstract
| Authors: | Taylor, M.; Antonia, S.; Bendell, J.; Calvo, E.; Jäger, D.; de Braud, F.; Ott, P. A.; Pietanza, M. C.; Horn, L.; Le, D. T.; Morse, M. A.; López-Martin, J. A.; Ascierto, P. A.; Christensen, O.; Simon, J. S.; Lin, C. S.; Eder, J. P. |
| Abstract Title: | Phase I/II study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032 |
| Meeting Title: | 30th Annual Scientific Meeting of the Society for Immunotherapy of Cancer (SITC 2015) |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 3 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2015 Nov 4-8 |
| Meeting Location: | National Harbor, MD |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2015-11-04 |
| Language: | English |
| DOI: | 10.1186/2051-1426-3-S2-P376 |
| PROVIDER: | manual |
| PMCID: | PMC4649441 |
| Notes: | Meeting Abstract: P376 |
